IBP-9414 for the Prevention of Necrotizing Enterocolitis
Public ClinicalTrials.gov record NCT02472769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double Blind, Parallel-group, Dose Escalation Placebo-controlled Multicenter Study to Investigate the Safety and Tolerability of IBP-9414 Administered in Preterm Infants.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Two different dose levels will be evaluated in two different birth weight categories, compared to placebo with regards to safety and tolerability.
Study identification
- NCT ID
- NCT02472769
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Up to 48 Hours
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 27, 2016 (Actual)
- Primary completion
- Aug 7, 2017 (Actual)
- Completion
- Aug 7, 2017 (Actual)
- Last update posted
- Dec 29, 2017
2016 – 2017
United States locations
- U.S. sites
- 15
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Univ. Arkansas Medical Sciences | Little Rock | Arkansas | 72202 | — |
| UCLA Medical Center | Los Angeles | California | 90095 | — |
| University Florida Health | Gainesville | Florida | 32610-0296 | — |
| Wolfson Children´s Hospital | Jacksonville | Florida | 32207 | — |
| UF Health Jacksonville | Jacksonville | Florida | 32209 | — |
| Jackson Memorial Hospital | Miami | Florida | 33136 | — |
| Memorial Hospital of South Bend | South Bend | Indiana | 46601 | — |
| Wesley Medical Center | Wichita | Kansas | 67214 | — |
| Kings County Hospital Center | Brooklyn | New York | 11203 | — |
| Duke University Medical Center | Durham | North Carolina | 27710 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| Hahnemann University Hospital | Philadelphia | Pennsylvania | 19102 | — |
| Einstein Medical Center of Philadelphia | Philadelphia | Pennsylvania | 19141 | — |
| Jackson Madison County General Hospital | Jackson | Tennessee | 38301 | — |
| Timpanogos Regional Hospital | Orem | Utah | 84057 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02472769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 29, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02472769 live on ClinicalTrials.gov.